STRATEGIC COOPERATION FROM SANTA FARMA and MEALIS
Santa Farma and Mealis signed a strategic cooperation agreement for the treatment of stress urinary incontinence in women.
Santa Farma, one of Turkey’s well-established local pharmaceutical companies, and MEALIS Middle East Life Sciences signed a strategic cooperation agreement.
Under the agreement, the sales, marketing and distribution rights of the active substance duloxetine hydrochloride were transferred to MEALIS.
Urinary incontinence is a common but treatable health problem, especially in women. In stress urinary incontinence, symptoms may increase during coughing, sneezing and physical exertion.
Patients experiencing complaints are advised to contact the nearest health institution.